Nexavar is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals Inc.. The primary component is Sorafenib.
Product ID | 50419-488_20ab7dba-4d59-4221-ad33-2dc86cd4f4e5 |
NDC | 50419-488 |
Product Type | Human Prescription Drug |
Proprietary Name | Nexavar |
Generic Name | Sorafenib |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2005-12-20 |
Marketing Category | NDA / NDA |
Application Number | NDA021923 |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Substance Name | SORAFENIB |
Active Ingredient Strength | 200 mg/1 |
Pharm Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2005-12-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021923 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-12-20 |
Ingredient | Strength |
---|---|
SORAFENIB | 200 mg/1 |
SPL SET ID: | b50667e4-5ebc-4968-a646-d605058dbef0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50419-488 | Nexavar | sorafenib |
0480-5425 | Sorafenib | Sorafenib |
24979-715 | Sorafenib | Sorafenib |
43598-458 | sorafenib | sorafenib |
51990-201 | Sorafenib | Sorafenib |
0378-1201 | Sorafenib Tosylate | Sorafenib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NEXAVAR 78670152 3537095 Live/Registered |
Bayer Aktiengesellschaft 2005-07-14 |
NEXAVAR 75943985 2745627 Live/Registered |
Bayer Aktiengesellschaft 2000-03-14 |